Intrexon reported $25.6M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agenus AGEN:US $ 163.06M 6.12M
Amgen AMGN:US $ 12886M 702M
Anika Therapeutics ANIK:US $ 26.99M 2.8M
Arrowhead Research ARWR:US $ 138.86M 1.82M
AstraZeneca AZN:LN 22740M 146M
Bluebird Bio BLUE:US $ 142.89M 10.1M
Bristol Myers Squibb BMY:US $ 22821M 953M
Chemocentryx CCXI:US $ 68.81M 5.79M
Gilead Sciences GILD:US $ 8558M 3052M
GlaxoSmithKline GSK:LN 24278M 608M
Heron Therapeutics HRTX:US $ 93M 21.94M
Immunogen IMGN:US $ 84.12M 16.83M
Intrexon XON:US $ 25.6M 9.04M
Karyopharm Therapeutics KPTI:US $ 66.34M 7.38M
Ligand Pharmaceuticals LGND:US $ 42.58M 0.91M
Macrogenics MGNX:US $ 67.1M 7.48M
Mannkind MNKD:US $ 53.49M 5.14M
Merk MRK:US $ 22316M 1556M
Novartis NOVN:VX SF 29807M 401M
Peregrine Pharmaceuticals PPHM:US $ 77.3M 7.77M
Rigel Pharmaceuticals RIGL:US $ 59.22M 4.33M
Sangamo Biosciences SGMO:US $ 118.53M 9.36M
Thermo Fisher Scientific TMO:US $ 12070M 1366M
Veracyte VCYT:US $ 62.54M 1.61M
Xencor XNCR:US $ 60.94M 9.8M
YTE INCY:US $ 886.16M 31.86M
Ziopharm Oncology ZIOP:US $ 21.23M 5.19M